Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Haichuan Hu, Ph.D.

Concepts

This page shows the publications Haichuan Hu has written about Receptor Protein-Tyrosine Kinases.
  1. ALK, ROS1 and RET fusions in 1139 lung adenocarcinomas: a comprehensive study of common and fusion pattern-specific clinicopathologic, histologic and cytologic features. Lung Cancer. 2014 May; 84(2):121-6.
    View in: PubMed
    Score: 0.079
  2. ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and RT-PCR. PLoS One. 2013; 8(7):e69016.
    View in: PubMed
    Score: 0.076
  3. The use of quantitative real-time reverse transcriptase PCR for 5' and 3' portions of ALK transcripts to detect ALK rearrangements in lung cancers. Clin Cancer Res. 2012 Sep 01; 18(17):4725-32.
    View in: PubMed
    Score: 0.070
  4. Analysis of major known driver mutations and prognosis in resected adenosquamous lung carcinomas. J Thorac Oncol. 2014 Jun; 9(6):760-8.
    View in: PubMed
    Score: 0.020
  5. Frequency of driver mutations in lung adenocarcinoma from female never-smokers varies with histologic subtypes and age at diagnosis. Clin Cancer Res. 2012 Apr 01; 18(7):1947-53.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.